Barclays
VNRX icon

Barclays’s VolitionRx Ltd VNRX Stock Holding History

Barclays’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482 Buy
+357
New +$861 ﹤0.01% 5012
2023
Q3 		– Sell
-118
Closed -$3.29K – 4719
2023
Q2 		$3.29K Hold
118
– – ﹤0.01% 4301
2023
Q1 		$4.51K Hold
118
– – ﹤0.01% 4836
2022
Q4 		$5.74K Hold
118
– – ﹤0.01% 4986
2022
Q3 		$3K Hold
118
– – ﹤0.01% 4594
2022
Q2 		$5K Sell
118
-1,359
-92% -$68.5K ﹤0.01% 4794
2022
Q1 		$89K Hold
1,477
– – ﹤0.01% 3842
2021
Q4 		$93K Buy
1,477
+1,319
+835% +$90K ﹤0.01% 3749
2021
Q3 		$10K Sell
158
-266
-63% -$16.8K ﹤0.01% 4521
2021
Q2 		$28K Sell
424
-1,074
-72% -$72.7K ﹤0.01% 4395
2021
Q1 		$113K Buy
1,498
+757
+102% +$64.9K ﹤0.01% 3953
2020
Q4 		$57K Sell
741
-177
-19% -$12.2K ﹤0.01% 4362
2020
Q3 		$59K Sell
918
-29
-3% -$1.97K ﹤0.01% 4514
2020
Q2 		$73K Buy
+947
New +$68.4K ﹤0.01% 4724
2019
Q4 		– Sell
-10
Closed -$1K – 6857
2019
Q3 		$1K Buy
+10
New +$796 ﹤0.01% 6620
2018
Q2 		– Hold
0
– – – 7320
2018
Q1 		– Hold
0
– – – 7358

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Barclays's VNRX Position: Q2 2026 in Review

Barclays opened a new position in VolitionRx Ltd (VNRX) in Q2 2026: 357 shares worth $482. The stake represents ﹤0.01% of the portfolio and ranks #5012 among its holdings. This is a return to the name: Barclays previously reported a position in VNRX as recently as Q2 2023.

Barclays first reported a position in VNRX in Q3 2019 and has held it in 15 quarters since. The position peaked at $113K in Q1 2021. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Barclays held 357 shares of VolitionRx Ltd worth $482 as of Q2 2026.
  • VolitionRx Ltd was a new Barclays position in Q2 2026.
  • VolitionRx Ltd made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5012 holding.
  • Barclays first reported a position in VolitionRx Ltd in Q3 2019 and has held it in 15 quarters since.
  • Barclays's VolitionRx Ltd position peaked at $113K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.